Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kezar Life Sciences Inc (KZR)

Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kezar Life Sciences Inc 4000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

www.kezarlifesciences.com P: 650-822-5600

Description:

Kezar Life Sciences, Inc. is a bio-technology company. It discovers and develops molecule therapeutics and medicines such as protein homeostasis for autoimmune disorders. The company's product pipeline consists of KZR-616 which is in clinical stage. Kezar Life Sciences, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 59,478
Enterprise Value, $K 34,058
Shares Outstanding, K 72,801
Annual Sales, $ 7,000 K
Annual Net Income, $ -101,870 K
Last Quarter Sales, $ 7,000 K
Last Quarter Net Income, $ -23,100 K
EBIT, $ -96,860 K
EBITDA, $ -102,390 K
60-Month Beta 0.47
% of Insider Shareholders 7.90%
% of Institutional Shareholders 67.90%
Float, K 67,050
% Float 92.10%
Short Volume Ratio 0.40

Growth:

1-Year Return -70.28%
3-Year Return -84.41%
5-Year Return -95.99%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 42.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 03/14/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -1.22
EPS Growth vs. Prev Qtr -9.38%
EPS Growth vs. Prev Year -40.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KZR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.08%
Return-on-Assets % -37.59%
Profit Margin % -1,455.29%
Debt/Equity 0.05
Price/Sales 8.54
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 2.97
Interest Coverage -64.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar